15 February 2021 Priya Vaidya 1185 Case Updates Neurim Pharmaceuticals v Generics UK Limited [2020] EWHC 3270 (Pat) byPriya Vaidya The case: A patent case relating to prolonged release pharmaceutical formulations in which the active ingredient melatonin is intended to improve the restorative quality of sleep in a patient suffering from primary insomnia characterised by non-restorative sleep. The case called for experts in sleep medicine. To continue reading you must be an EWI member, become a member and access exclusive content. Already a member? Login Share Print Tags Bias06. Rules and Regulations11. Report Writing Related articles An expert report that is entirely equivocal on the key issues is of little assistance to the court The diagnosis hang-up and cardiological manifestations of PTSD Expert suggests Google would probably give the court a better answer than him A Day in the Life of a Plastic, Aesthetic and Hair transplant Surgeon and Expert Witness Disability and exclusion from school Switch article R (IJ (Kosovo)) v Secretary of State for the Home Department [2020] EWHC 3487 (Admin) Previous Article B v A [2020] EWHC 3138 (Fam) Next Article Comments are only visible to subscribers.